{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T16:53:29Z","timestamp":1649091209533},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.acuro.2014.11.005","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T22:32:35Z","timestamp":1420842755000},"page":"217-221","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factores que influyen en los resultados urodin\u00e1micos de la toxina botul\u00ednica en el tratamiento de la hiperactividad neur\u00f3gena"],"prefix":"10.1016","volume":"39","author":[{"given":"P.","family":"Guti\u00e9rrez-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"V\u00edrseda-Chamorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Salinas Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"G\u00f3mez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Esteban-Fuertes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.acuro.2014.11.005_bib0005","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/nau.22631","article-title":"Chapter 4: Guidelines for the diagnosis and treatment of overactive bladder (OAB) and neurogenic detrusor overactivity (NDO)","volume":"33","author":"Nambiar","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2014.11.005_bib0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000353274","article-title":"Systematic review of the epidemiology of urinary incontinence and detrusor overactivity among patients with neurogenic overactive bladder","volume":"41","author":"Ruffion","year":"2013","journal-title":"Neuroepidemiology"},{"issue":"Suppl 3","key":"10.1016\/j.acuro.2014.11.005_bib0015","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1002\/nau.22635","article-title":"Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of overactive bladder","volume":"33","author":"Chapple","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2014.11.005_bib0020","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0022-5347(17)37254-3","article-title":"Risk factors for upper tract deterioration in chronic spinal cord injury patients","volume":"147","author":"Gerridzen","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2014.11.005_bib0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2009.04.028","article-title":"EAU guidelines on neurogenic lower urinary tract dysfunction","volume":"56","author":"St\u00f6hrer","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2014.11.005_bib0030","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sc.2013.19","article-title":"Neurogenic detrusor overactivity in adults: A review on efficacy, tolerability and safety of oral antimuscarinics","volume":"51","author":"Madersbacher","year":"2013","journal-title":"Spinal Cord"},{"key":"10.1016\/j.acuro.2014.11.005_bib0035","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.apmr.2013.04.011","article-title":"Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury","volume":"94","author":"Mehta","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.acuro.2014.11.005_bib0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2014.11.005_bib0045","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","article-title":"Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure-flow studies","volume":"21","author":"Sch\u00e4fer","year":"2002","journal-title":"Neurourol Urodynam"},{"key":"10.1016\/j.acuro.2014.11.005_bib0050","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxin A for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"Ginsberg","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2014.11.005_bib0055","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.juro.2011.02.004","article-title":"Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: A randomized, double-blind trial","volume":"185","author":"Herschorn","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2014.11.005_bib0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: Results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2014.11.005_bib0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: A randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2014.11.005_bib0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2490-14-66","article-title":"A pilot prospective study to evaluate whether the bladder morphology in cystography and\/or urodynamic may help predict the response to botulinum toxin a injection in neurogenic bladder refractory to anticholinergics","volume":"14","author":"Alvares","year":"2014","journal-title":"BMC Urol"},{"key":"10.1016\/j.acuro.2014.11.005_bib0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/nau.20515","article-title":"Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients","volume":"27","author":"Mascarenhas","year":"2008","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2014.11.005_bib0080","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ucl.2010.06.001","article-title":"Botulinum toxin therapy for neurogenic detrusor overactivity","volume":"37","author":"Smaldone","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.acuro.2014.11.005_bib0085","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.juro.2007.08.032","article-title":"Botulinum-A toxin: Solo treatment for neuropathic noncompliant bladder","volume":"178","author":"Neel","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2014.11.005_bib0090","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0022-5347(05)67157-1","article-title":"Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury","volume":"164","author":"Esclar\u00edn","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2014.11.005_bib0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1464-410x.1999.00171.x","article-title":"The impact of contemporary bladder management techniques on struvite calculi associated with spinal cord injury","volume":"84","author":"Donnellan","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2014.11.005_bib0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/nau.1930020207","article-title":"Long term urethral catheter drainage and bladder capacity","volume":"2","author":"Kristiansen","year":"1983","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2014.11.005_bib0105","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.eururo.2010.06.035","article-title":"Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses","volume":"58","author":"Grise","year":"2010","journal-title":"Eur Urol."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480614004148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480614004148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T13:58:08Z","timestamp":1566223088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480614004148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0210480614004148"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2014.11.005","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factores que influyen en los resultados urodin\u00e1micos de la toxina botul\u00ednica en el tratamiento de la hiperactividad neur\u00f3gena","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2014.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 AEU. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}